Covestro AG (1COV):企業の財務・戦略的SWOT分析

◆英語タイトル:Covestro AG (1COV) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDCH7899FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年3月
◆ページ数:60
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:Chemicals
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Covestro AG (1COV) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Covestro AG (Covestro) is a provider of high-tech polymer. It develops and manufactures raw materials for polyurethanes, and their derivatives, coatings, adhesives and other specialties, polycarbonates and specialty chemicals. The company also manufactures and markets chlorine and by-products such as styrene. The company provides its offerings to various markets such as automotive, construction, fashion and sportswear, electrical and electronics, cosmetics, health, chemical, and wood processing and furniture. It operates research laboratories, technical service centers and sales offices across the world. The company has operations in North America, South America, Europe, Asia-Pacific, the Middle East and Africa. Covestro is headquartered in Leverkusen, Germany.

Covestro AG Key Recent Developments

Feb 23,2021: Covestro successfully navigates exceptional year 2020
Jan 27,2021: Covestro receives first delivery of sustainable benzene from Total
Jan 14,2021: Covestro receives ISCC Plus certification for its Antwerp and Uerdingen sites
Oct 27,2020: Covestro with significant growth in volume and earnings in third quarter
Oct 21,2020: Borealis delivers first consignment of renewable phenol to Covestro

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Covestro AG – Key Facts
Covestro AG – Key Employees
Covestro AG – Key Employee Biographies
Covestro AG – Major Products and Services
Covestro AG – History
Covestro AG – Company Statement
Covestro AG – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
Covestro AG – Business Description
Business Segment: All Other Segments
Overview
Performance
Business Segment: Coatings, Adhesives, Specialties
Overview
Performance
Business Segment: Polycarbonates
Overview
Performance
Business Segment: Polyurethanes
Overview
Performance
Geographical Segment: APAC
Performance
Geographical Segment: EMLA
Performance
Geographical Segment: NAFTA
Performance
R&D Overview
Covestro AG – Corporate Strategy
Covestro AG – SWOT Analysis
SWOT Analysis – Overview
Covestro AG – Strengths
Covestro AG – Weaknesses
Covestro AG – Opportunities
Covestro AG – Threats
Covestro AG – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s, Power Financial Deals and Alliances
Covestro AG, Petrochemicals, Deals By Year, 2015 to YTD 2021
Covestro AG, Petrochemicals, Deals By Type, 2015 to YTD 2021
Covestro AG, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 23, 2021: Covestro successfully navigates exceptional year 2020
Jan 27, 2021: Covestro receives first delivery of sustainable benzene from Total
Jan 14, 2021: Covestro receives ISCC Plus certification for its Antwerp and Uerdingen sites
Oct 27, 2020: Covestro with significant growth in volume and earnings in third quarter
Oct 21, 2020: Borealis delivers first consignment of renewable phenol to Covestro
Oct 20, 2020: Covestro receives first supply of certified renewable phenol for polycarbonates from Borealis
Oct 09, 2020: Covestro: Preliminary EBITDA of EUR 456 million in Q3 2020 above market expectation; FY 2020 outlook updated
Oct 07, 2020: Covestro operates new production line in Thailand
Aug 12, 2020: Covestro, Goldwind and LZ Blades develop world’s first 64.2-meter full polyurethane wind turbine blade
Jul 23, 2020: Covestro announces Q2 2020 results significantly impacted by the coronavirus pandemic as expected
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Covestro AG, Key Facts
Covestro AG, Key Employees
Covestro AG, Key Employee Biographies
Covestro AG, Major Products and Services
Covestro AG, History
Covestro AG, Subsidiaries
Covestro AG, Joint Venture
Covestro AG, Key Competitors
Covestro AG, Ratios based on current share price
Covestro AG, Annual Ratios
Covestro AG, Annual Ratios (Cont...1)
Covestro AG, Annual Ratios (Cont...2)
Covestro AG, Interim Ratios
Covestro AG, Petrochemicals, Deals By Year, 2015 to YTD 2021
Covestro AG, Petrochemicals, Deals By Type, 2015 to YTD 2021
Covestro AG, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Covestro AG (1COV):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Kala Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Kala Pharmaceuticals Inc (Kala Pharmaceuticals) is a clinical stage pharmaceutical company which focuses on nanoparticle-based treatments for ocular diseases affecting both front and back of the eye. The company’s lead program MPP nanosuspension of an ophthalmic corticosteroid is under phase …
  • Shibuya Kogyo Co., Ltd.:企業の戦略・SWOT・財務情報
    Shibuya Kogyo Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Shibuya Kogyo Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Theradex Systems Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Theradex Systems Inc (Theradex) is a research organization that provides clinical trials monitoring services. The organization develops medical devices, pharmaceutical compounds and diagnostic tests in the areas of oncology and life-threatening diseases. It provides services such as clinical …
  • VistaGen Therapeutics Inc (VTGN):医療機器:M&Aディール及び事業提携情報
    Summary VistaGen Therapeutics Inc (VistaGen) is a clinical stage biopharmaceutical company that develops new generation medicines for depression and neuropsychiatric disorders. The company’s pipeline product, AV-101, currently under Phase 2 clinical development, is an oral N-methyl-D-aspartate recep …
  • Grain Processing Corp:企業の戦略的SWOT分析
    Grain Processing Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • PharmaZell GmbH:企業の戦略的SWOT分析
    PharmaZell GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Compagnie Generale des Etablissements Michelin:企業の戦略・SWOT・財務情報
    Compagnie Generale des Etablissements Michelin - Strategy, SWOT and Corporate Finance Report Summary Compagnie Generale des Etablissements Michelin - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, ope …
  • Volta River Authority-エネルギー分野:企業M&A・提携分析
    Summary Volta River Authority (VRA) is a state-owned energy utility that generates, transmits, and distributes electricity. The authority produces power from solar, hydro, light crude oil, distillate fuel oil, and heavy fuel oil sources. It procures energy from Takoradi International Company Ltd; an …
  • Wabash Valley Power Association Inc:企業の戦略的SWOT分析
    Wabash Valley Power Association Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • LifeScan Inc-医療機器分野:企業M&A・提携分析
    Summary LifeScan Inc (LifeScan), a subsidiary of the Johnson & Johnson, develops, manufactures and markets blood glucose monitoring solutions for hospital and home use. The company’s product portfolio includes blood glucose meters; test strips and control solutions; lancing devices; diabetes managem …
  • Sagent Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Sagent Pharmaceuticals Inc (Sagent), formerly Sagent Holding Co, a subsidiary of Nichi-Iko Pharmaceutical Co Ltd, is a biopharmaceutical company that develops and manufactures injectable products. The company offers products such as amikacin sulfate injection, USP, ampicillin and sulbactam f …
  • Maxeda B.V.:企業の戦略・SWOT・財務情報
    Maxeda B.V. - Strategy, SWOT and Corporate Finance Report Summary Maxeda B.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Providence Health & Services-製薬・医療分野:企業M&A・提携分析
    Summary Providence Health & Services (Providence) is a not for profit organization which offers health care services to its communities in Alaska, Washington, Montana, Oregon and California. The organization operates hospitals and physician clinics, and, provides senior services, supportive housing …
  • Bowler Metcalf Limited:企業の戦略・SWOT・財務情報
    Bowler Metcalf Limited - Strategy, SWOT and Corporate Finance Report Summary Bowler Metcalf Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Apollo Computing Laboratories (P) Ltd.:企業の戦略・SWOT・財務情報
    Apollo Computing Laboratories (P) Ltd. - Strategy, SWOT and Corporate Finance Report Summary Apollo Computing Laboratories (P) Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Pampa Energia SA (PAMP):石油・ガス:M&Aディール及び事業提携情報
    Summary Pampa Energia SA (Pampa) is an independent integrated energy company. It generates, distributes and transmits electricity; and explores and produces, refines oil and gas, and petrochemicals and commercializes and transports them. The company produces electricity using coal, wind, hydro, and …
  • aTyr Pharma Inc (LIFE):企業の財務・戦略的SWOT分析
    Summary ATyr Pharma Inc (ATyr Pharma) is a clinical-stage biotechnology company engaged in the discovery and clinical development of medicines for the treatment of cancer and lung diseases. The company’s ATYR1923 is a clinical-stage product candidate, based on the resokine pathway, which binds to th …
  • Candover Investments plc (CDI):企業の財務・戦略的SWOT分析
    Candover Investments plc (CDI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Avillion Berhad
    Avillion Berhad - Strategy, SWOT and Corporate Finance Report Summary Avillion Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • PT. Bank Rakyat Indonesia (Persero) Tbk.:企業の戦略・SWOT・財務情報
    PT. Bank Rakyat Indonesia (Persero) Tbk. - Strategy, SWOT and Corporate Finance Report Summary PT. Bank Rakyat Indonesia (Persero) Tbk. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆